InvestSMART

The article you are trying to access does not exist, however, here are some articles you may be interested in.

Bio-Gene Technology Ltd (ASX: BGT) - Announcements

- Current share price for BGT : $0.015

ASX company news and announcements for Bio-Gene Technology Ltd (BGT) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Bio-Gene Technology Ltd (BGT) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Bio-Gene Technology Ltd (BGT), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Bio-Gene Technology Ltd (BGT)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$7 Notification of cessation of securities - BGT 2 Dec 2024 1:34PM $0.044 $0.015 fallen by 65.91%
$7 Results of Meeting 29 Nov 2024 1:41PM $0.044 $0.015 fallen by 65.91%
$7 CEO's Address to Shareholders 29 Nov 2024 11:10AM $0.044 $0.015 fallen by 65.91%
$7 CEO's Presentation 29 Nov 2024 11:10AM $0.044 $0.015 fallen by 65.91%
$7 Chair's Address to Shareholders 29 Nov 2024 11:06AM $0.044 $0.015 fallen by 65.91%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 31 Oct 2024 8:22AM $0.058 $0.015 fallen by 74.14%
$7 Notice of Annual General Meeting/Proxy Form 29 Oct 2024 9:04AM $0.054 $0.015 fallen by 72.22%
$7 Bio-Gene Receives $535000 R&D Tax Incentive 25 Oct 2024 8:19AM $0.055 $0.015 fallen by 72.73%
$7 Date of 2024 Annual General Meeting 4 Oct 2024 8:26AM $0.055 $0.015 fallen by 72.73%
$7 BGT Investor Presentation Oct24 2 Oct 2024 8:50AM $0.048 $0.015 fallen by 68.75%
$7 Investor Webinar Presentation 06 Sep 24 6 Sep 2024 8:42AM $0.046 $0.015 fallen by 67.39%
$7 Investor Webinar - Shareholder update 06 SEP 24 2 Sep 2024 9:29AM $0.044 $0.015 fallen by 65.91%
$7 Bio-Gene & Rallis achieve key Flavocide production milestone 2 Sep 2024 8:40AM $0.044 $0.015 fallen by 65.91%
$7 Appendix 4G and 2024 Corporate Governance Statement 28 Aug 2024 9:10AM $0.045 $0.015 fallen by 66.67%
$7 Appendix 4E and 2024 Annual Report 28 Aug 2024 8:58AM $0.045 $0.015 fallen by 66.67%
$7 Envu collaboration on Flavocide for mosquito management 14 Aug 2024 8:20AM $0.053 $0.015 fallen by 71.70%
$7 APVMA Pre Application Assistance 8 Aug 2024 8:33AM $0.047 $0.015 fallen by 68.09%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 30 Jul 2024 8:32AM $0.043 $0.015 fallen by 65.12%
$7 Company Secretary Appointment/Resignation 17 May 2024 4:01PM $0.061 $0.015 fallen by 75.41%
$7 Notification of cessation of securities - BGT 6 May 2024 4:13PM $0.069 $0.015 fallen by 78.26%
$7 Quarterly Activities/Appendix 4C Cash Flow Report 29 Apr 2024 9:40AM $0.075 $0.015 fallen by 80%
$7 Appointment of CFO and Joint Company Secretary 8 Apr 2024 9:55AM $0.075 $0.015 fallen by 80%
$7 Investor Webinar - FY24 Half Year Review 5 Mar 2024 10:08AM $0.038 $0.015 fallen by 60.53%
$7 Appendix 4D - Half Year Accounts - 31 December 2023 26 Feb 2024 9:45AM $0.050 $0.015 fallen by 70%
$7 Appendix 4C - 31 December 2023 29 Jan 2024 8:49AM $0.058 $0.015 fallen by 74.14%

101 - 125 of 485 results

Page 5 of 20

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.